Today we received the formal documentation of our first US patent granted, with two more patent applications in process since we founded July 2018. We’re an R&D-intensive software as medical device company with a mission to transform radiology using machinelearning in medicalimaging to build workflow solutions, and although we disseminate knowledge through substantial research publications, protecting our IPR is key to any company building sustainable innovative technology for the future.
- Eurostars Apollo Consortia Agreement Signed May 7, 2020
- Cerebriu featured in Health Europa: Machine learning for diagnostic medical imaging May 5, 2020
- Artificial intelligence to identify COVID-19 patients’ need for intensive care April 28, 2020
- Texture analysis could help quantifying COPD on CT April 14, 2020
- Cerebriu enters COVID-19 research deal April 6, 2020